At MODAG, we combine the expertise of our renowned scientists and experienced industry experts with the power of strong partnerships to create breakthrough innovations in the treatment of neurodegenerative diseases.<\/p>\n
This internal expertise, coupled with strategic collaborations, is our engine that enables us to achieve exceptional results and push the boundaries of what is possible.<\/p>\n
Our network extends across renowned institutions such as the Ludwig Maximilian University of Munich<\/b>, the Max Planck Institute for Biophysical Chemistry in G\u00f6ttingen<\/b> and the University of T\u00fcbingen<\/strong>. These alliances, combined with the deep expertise of our leadership team, give us access to cutting-edge research, advanced technologies and clinical expertise that are essential to our mission. <\/p>\nThe support of the Michael J. Fox Foundation for Parkinson’s Research<\/b> drives our research forward, while Bayerische Patentallianz GmbH<\/b> helps us to protect and commercialize our innovations.<\/p>\n
Together with patient organizations such as Parkinson’s UK,<\/b><\/span> Cure Parkinson’s Trust, MSA Trust <\/b>and MSA Coalition <\/b>, we ensure that our work always focuses on the needs of those affected.<\/p>\nThese synergies between internal expertise and external partnerships enable us to overcome challenges that would be insurmountable for a single company. <\/span><\/p>\nEvery collaboration, whether internal or external, brings us one step closer to our goal: the development of life-changing therapies for patients with neurodegenerative diseases.<\/b><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>
Our corporate culture and values<\/span><\/p>\n<\/div>